Chicago Equity Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$34K Sell
11,940
-170,570
-93% -$550K ﹤0.01% 642
2019
Q4
$592K Sell
182,510
-336,805
-65% -$978K 0.03% 599
2019
Q3
$1.12M Sell
519,315
-27,172
-5% -$72.6K 0.05% 460
2019
Q2
$1.72M Buy
546,487
+442,247
+424% +$1.43M 0.08% 369
2019
Q1
$388K Hold
104,240
0.02% 724
2018
Q4
$302K Buy
+104,240
New +$286K 0.01% 731
2018
Q1
Sell
-461,100
Closed -$1.26M 851
2017
Q4
$1.26M Buy
+461,100
New +$1.42M 0.04% 453
2014
Q4
Sell
-20,180
Closed -$150K 510
2014
Q3
$150K Sell
20,180
-9,670
-32% -$89.8K ﹤0.01% 435
2014
Q2
$288K Sell
29,850
-1,525
-5% -$13.6K 0.01% 373
2014
Q1
$260K Buy
31,375
+425
+1% +$3.64K 0.01% 405
2013
Q4
$261K Buy
+30,950
New +$261K 0.01% 374

Other funds holding PDLI